Biomarkers for chronic fatigue

Brain, Behavior, and Immunity

Volumn 26, Issue 8, 2012, Pages 1202-1210

  Klimas, Nancy G ^a,d   Broderick, Gordon ^b   Fletcher, Mary Ann ^a,c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF ALBERTA   (Canada)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^d NOVA SOUTHEASTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

AUTONOMIC DYSFUNCTION; CHRONIC FATIGUE SYNDROME; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNE RESPONSE; INFLAMMATION; PRIORITY JOURNAL; REVIEW;

ANIMALS; BIOLOGICAL MARKERS; CHRONIC DISEASE; FATIGUE; FATIGUE SYNDROME, CHRONIC; HUMANS; INFLAMMATION; TREATMENT OUTCOME;

EID: 84867225089     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2012.06.006     Document Type: Review

References (83)

1. Albright F., Light K., Light A., Bateman L., Cannon-Albright L.A. Evidence for a heritable predisposition to chronic fatigue syndrome. BMC Neurol. 2011, 11:62.
2. Allin K.H., Nordestgaard B.G. Elevated C-reactive protein in the diagnosis, prognosis, and cause of cancer. Crit. Rev. Clin. Lab Sci. 2011, 48:155-170.
3. Al-shair K., Kolsum U., Dockry R., Morris J., Singh D., Vestbo J. Biomarkers of systemic inflammation and depression and fatigue in moderate clinically stable COPD. Respir. Res. 2011, 12:3.
4. Baraniuk J.B., Casado B., Maibach H., Clauw D.H., Pannell LK., Hess S.A. Chronic fatigue syndrome - related proteome in human cerebrospinal fluid. BMC Neurol. 2005, 22.
5. Basu A., Lazovic J., Krady J.K., Mauger D.T., Rothstein R.P., Smith M.B., Levison S.W. Interleukin-1 and the interleukin-1 type 1 receptor are essential for the progressive neurodegeneration that ensues subsequent to a mild hypoxic/ischemic injury. J. Cereb. Blood Flow Metab. 2005, 25:17-29.
6. Ben-Zvi A., Vernon S.D., Broderick G. Model-based therapeutic correction of hypothalamic-pituitary-adrenal axis dysfunction. PLoS Comput. Biol. 2009, 1:e1000273.
7. Bou-Holaigah I., Rowe P.C., Kan J., Calkins H. The relationship between neurally mediated hypotension and the chronic fatigue syndrome. JAMA 1995, 274:961-967.
8. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin. Pharmacol. Ther. 2001, 69:89-95. Biomarkers Definitions Working Group.
9. Boncler M., Watała C. Regulation of cell function by isoforms of C-reactive protein: a comparative analysis. Acta Biochim. Pol. 2009, 56:17-31.
10. Bower, J.E., 2007. Cancer-related fatigue: links with inflammation in cancer patients and survivors. Brain Behav. Immun. 21, 863-871. Review.
11. Bower J.E., Ganz P.A., Irwin M.R., Arevalo J.M., Cole S.W. Fatigue and gene expression in human leukocytes: increased NF-κB and decreased glucocorticoid signaling in breast cancer survivors with persistent fatigue. Brain Behav. Immun. 2011, 25:147-150.
12. Bower J.E., Ganz P.A., Irwin M.R., Kwan L., Breen E.C., Cole S.W. Inflammation and behavioral symptoms after breast cancer treatment: do fatigue, depression, and sleep disturbance share a common underlying mechanism?. J. Clin. Oncol. 2011, 29:3517-3522.
13. Bower J.E., Ganz P.A., Tao M.L., Hu W., Belin T.R., Sepah S., Cole S., Aziz N. Inflammatory biomarkers and fatigue during radiation therapy for breast and prostate cancer. Clin. Cancer Res. 2009, 15:5534-5540.
14. Brenu E.W., van Driel M.L., Staines D.R., Ashton K.J., Ramos S.B., Keane J., Klimas N.G., Marshall-Gradisnik S.M. Immunological abnormalities as potential biomarkers in chronic fatigue syndrome/myalgicencephalomyelitis. J. Transl. Med. 2011, 28(9):81.
15. Broderick G., Craddock R.C., Whistler T., Taylor R., Klimas N., Unger E.R. Identifying illness parameters in fatiguing syndromes using classical projection methods. Pharmacogenomics 2006, 7:407-419.
16. Broderick G., Fuite J., Kreitz A., Vernon S.D., Klimas N., Fletcher M.A. A formal analysis of cytokine networks in chronic fatigue syndrome. Brain Behav. Immun. 2010, 24. 1209-174.
17. Broderick G., Klimas, N.G., Fletcher, M.A., Efroni, S., 2011. From cytokines to cells to gene expression: an integrative approach to the study of gulf war illness systems biology. Presentation to the Research Advisory Committee on Gulf War Veterans Illnesses. Washington, D.C. Available at: <>. http://www.va.gov/RAC-GWVI/Minutes_June_2011.asp.
18. Byrnes A., Jacks A., Dahlman-Wright K., Evengard B., Wright F.A., Pedersen N.L., Sullivan P.F. Gene expression in peripheral blood leukocytes in monozygotic twins discordant for chronic fatigue: no evidence of a biomarker. PLoS One 2009, 4(6):e5805.
19. Carruthers B.M., van de Sande M.I., DeMeirleir K.L., Klimas N.G., Broderick G., Mitchell T., Staines D., Powles A.C., Speight N., Vallings R., Bateman L., Baumgarten-Austrheim B., Bell D.S., Carlo-Stella N., Chia J., Darragh A., Jo D., Lewis D., Light A.R., Marshall-Gradisbik S., Mena I., Mikovits J.A., Miwa K., Murovska M., Pall M.L., Stevens S. Myalgic encephalomyelitis: international consensus criteria. J. Intern. Med. 2011, 270:327-338.
20. Crouse, K., 2011. US Open: Venus Williams describes fights with fatigue, New York Times, Sports Friday, September 2.
21. Dantzer R. Cytokine-induced sickness behavior: where do we stand?. Brain Behav. Immun. 2001, 15:7-24.
22. Davis M.C., Zautra A.J., Younger J., Motivala S.J., Attrep J., Irwin M.R. Chronic stress and regulation of cellular markers of inflammation in rheumatoid arthritis: implications for fatigue. Brain Behav. Immun. 2008, 22:24-32.
23. Efron I.S., Schaefer C.F., Buetow K.H. Identification of key processes underlying cancer phenotypes using biologic pathway analysis. PLoS One 2007, 2(5):e425.
24. Evengård B., Klimas N. Chronic fatigue syndrome: probable pathogenesis and possible treatments. Drugs 2002, 62:2433-2446.
25. Fagundes C.P., Glaser R., Alfano C.M., Bennett J.M., Povoski S.P., Lipari A.M., Agnese D.M., Yee L.D., Carson W.E., Farrar W.B., Malarkey W.B., Kiecolt-Glaser J.K. Fatigue and herpesvirus latency in women newly diagnosed with breast cancer. Brain Behav. Immun. 2012, 26:394-400.
26. Fernández-de-Las-Peñas C., Cantarero-Villanueva I., Fernández-Lao C., Ambite-Quesada S., Díaz-Rodríguez L., Rivas-Martínez I., Moral-Avila R.D., Arroyo-Morales M. Influence of catechol-o-methyltransferase genotype (Val158Met) on endocrine, sympathetic nervous and mucosal immune systems in breast cancer survivors. Breast 2012, 21:199-203.
27. Flachenecker P., Bihler I., Weber F., Gottschalk M., Toyka K.V., Rieckmann P. Cytokine mRNA expression in patients with multiple sclerosis and fatigue. Mult. Scler. 2004, 10:165-169.
28. Fletcher M.A., Zeng X.R., Barnes Z., Levis S., Klimas N.G. Plasma cytokines in women with chronic fatigue syndrome. J. Transl. Med. 2009, 7:96.
29. Fletcher M.A., Zeng X.R., Maher K., Levis S., Hurwitz B., Antoni M., Broderick G., Klimas N.G. Biomarkers in chronic fatigue syndrome: evaluation of natural killer cell function and dipeptidyl peptidase IV/CD26. PLoS One 2010, 5(5):e10817.
30. Fletcher M.A., Rosenthal M., Antoni M., Ironson G., Zeng X.R., Barnes Z., Harvey J.M., Hurwitz B., Levis S., Broderick G., Klimas N.G. Plasma neuropeptide Y: a biomarker for symptom severity in chronic fatigue syndrome. Behav. Brain Funct. 2010, 6:76.
31. Frampton D., Kerr J., Harrison T.J., Kellam P. Assessment of a 44 gene classifier for the evaluation of chronic fatigue syndrome from peripheral blood mononuclear cell gene expression. PLoS One 2011, 6(3):e16872.
32. Fuite J., Vernon S.D., Broderick G. Neuroendocrine and immune network re-modeling in chronic fatigue syndrome: an exploratory analysis. Genomics 2008, 92:393-399.
33. Fukuda K., Straus S.E., Hickie I., Sharpe M.C., Dobbins J.G., Komaroff A. The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann. Int. Med. 1994, 121:953-959.
34. Gaab J., Rohleder N., Heitz V., Engert V., Schad T., Schürmeyer T.H., Ehlert U. Stress-induced changes in LPS-induced pro-inflammatory cytokine production in chronic fatigue syndrome. Psychoneuroendocrinology 2005, 30:188-198.
35. Glaser R., Padgett D.A., Litsky M.L., Baiocchi R.A., Yang E.V., Chen M., Yeh P.E., Klimas N.G., Marshall G.D., Whiteside T., Herberman R., Kiecolt-Glaser J., Williams M.V. Stress-associated changes in the steady-state expression of latent Epstein-Barr virus: implications for chronic fatigue syndrome and cancer. Brain Behav. Immun. 2005, 19:91-103.
36. Gold S.M., Krüger S., Ziegler K.J., Krieger T., Schulz K.H., Otte C., Heesen C. Endocrine and immune substrates of depressive symptoms and fatigue in multiple sclerosis patients with comorbid major depression. J. Neurol. Neurosurg. Psychiatry 2011, 82:814-818.
37. Graff L.A., Vincent N., Walker J.R., Clara I., Carr R., Ediger J., Miller N., Rogala L., Rawsthorne P., Lix L., Bernstein C.N. A population-based study of fatigue and sleep difficulties in inflammatory bowel disease. Inflamm. Bowel Dis. 2011, 17:1882-1889.
38. Harboe E., Tjensvoll A.B., Vefring H.K., Gøransson L.G., Kvaløy J.T., Omdal R. Fatigue in primary Sjögren's syndrome-a link to sickness behavior in animals?. Brain Behav. Immun. 2009, 23:1104-1108.
39. van Hoogmoed D., Fransen J., Bleijenberg G., van Riel P. Physical and psychosocial correlates of severe fatigue in rheumatoid arthritis. Rheumatology 2010, 49:1294-1302.
40. Hurwitz B.E., Coryell V.T., Parker M., Martin P., Laperriere A., Klimas N.G., Sfakianakis G.N., Bilsker M.S. Chronic fatigue syndrome: illness severity, sedentary lifestyle, blood volume and evidence of diminished cardiac function. Clin. Sci. (London) 2009, 118:125-135.
41. Jammes Y., Steinberg J.G., Delliaux S., Brégeon F. Chronic fatigue syndrome combines increased exercise-induced oxidative stress and reduced cytokine and Hsp responses. J. Int. Med. 2009, 266:196-206.
42. Jason L.A., Richman J.A., Rademaker A.W. A community-based study of chronic fatigue syndrome. Arch. Int. Med. 1999, 159:2129-2137.
43. Jelsness-Jørgensen L.P., Bernklev T., Henriksen M., Torp R., Moum B.A. Chronic fatigue is more prevalent in patients with inflammatory bowel disease than in healthy controls. Inflamm. Bowel Dis. 2011, 17:1564-1572.
44. Kerr J.R., Petty R., Burke B., Gough J., Fear D., Sinclair L.I., Mattey D.L., Richards S.C., Montgomery J., Baldwin D.A., Kellam P., Harrison T.J., Griffin G.E., Main J., Enlander D., Nutt D.J., Holgate S.T. Gene expression subtypes in patients with chronic fatigue syndrome/myalgic encephalomyelitis. J. Infect. Dis. 2008, 197:1171-1184.
45. Kwak S.M., Choi Y.S., Yoon H.M., Kim D.G., Song S.H., Lee Y.J., Yeom C.H., Koh S.J., Park J., Lee M.A., Suh S.Y. The relationship between interleukin-6, tumor necrosis factor-{alpha}, and fatigue in terminally ill cancer patients. Palliat. Med. 2011, 26:275-282.
46. Lattie E., Antoni, M.H., Fletcher, M.A., Penedo, F., Czaja, S., Lopez, C., Perdomo, D., Sala, A., Nair, S. Fu, S., Klimas, N., 2012. Stress management skills, neuroimmune processes and fatigue levels in persons with chronic fatigue syndrome. Brain Behav. Immun., in press.
47. Lee, H.M., Sugino, H., Nishimoto, N., 2010. Cytokine networks in systemic lupus erythematosus. J. Biomed. Biotechnol. 676284. Epub 2010 Apr 15.
48. Lee T.W., Iser J.H., Sparrow M.P., Newnham E.D., Headon B.J., Gibson P.R. Thiopurines, a previously unrecognised cause for fatigue in patients with inflammatory bowel disease. J. Crohns Colitis. 2009, 3:196-199.
49. Light A.R., White A.T., Hughen R.W., Light K.C. Moderate exercise increases expression for sensory, adrenergic, and immune genes in chronic fatigue syndrome patients but not in normal subjects. J. Pain 2009, 10:1099-1112.
50. Light A.R., Bateman L., Jo D., Hughen R.W., Vanhaitsma T.A., White A.T., Light K.C. Gene expression alterations at baseline and following moderate exercise in patients with Chronic Fatigue Syndrome and Fibromyalgia Syndrome. J. Int. Med. 2012, 271:64-81.
51. Liu, L., Mills, P.J., Rissling, M., Fiorentino, L., Natarajan, L., Dimsdale, J.E., Sadler, G.R., Parker, B.A., Ancoli-Israel, S., 2012. Fatigue and sleep quality are associated with changes in inflammatory markers in breast cancer patients undergoing chemotherapy. Brain Behav. Immun. (Epub ahead of print).
52. Loge J., Ekeberg O., Kaasa S. Fatigue in the general Norwegian population: normative data and associations. J. Psychosom. Res. 1998, 45:53-65.
53. Maes M., Coucke F., Leunis J.C. Normalization of the increased translocation of endotoxin from gram negative enterobacteria (leaky gut) is accompanied by a remission of chronic fatigue syndrome. Neuro. Endocrinol. Lett. 2007, 28:739-744.
54. Maher K.J., Klimas N.G., Fletcher M.A. Chronic fatigue syndrome is associated with diminished intracellular perforin. Clin. Exp. Immunol. 2005, 142:505-511. available from .
55. Maloney E.M., Boneva R.S., Lin J.M., Reeves W.C. Chronic fatigue syndrome is associated with metabolic syndrome: results from a case-control study in Georgia. Metabolism 2010, 59:1351-1357.
56. Mills P.J., Kim J.H., Bardwell W., Hong S., Dimsdale J.E. Predictors of fatigue in obstructive sleep apnea. Sleep Breath 2008, 12:397-399.
57. Miwa K., Fujita M. Fluctuation of serum vitamin E (alpha-tocopherol) concentrations during exacerbation and remission phases in patients with chronic fatigue syndrome. Heart Vessels 2010, 25:319-323.
58. Murrough J.W., Mao X., Collins K.A., Kelly C., Andrade G., Nestadt P., Levine S.M., Mathew S.J., Shungu D.C. Increased ventricular lactate in chronic fatigue syndrome measured by 1H MRS imaging at 3.0 T. II: comparison with major depressive disorder. NMR Biomed. 2010, 23:643-650.
59. Myhill S., Booth N.E., McLaren-Howard J. Chronic fatigue syndrome and mitochondrial dysfunction. Int. J. Clin. Exp. Med. 2009, 2:1-16.
60. Orre I.J., Murison R., Dahl A.A., Ueland T., Aukrust P., Fosså S.D. Levels of circulating interleukin-1 receptor antagonist and C-reactive protein in long-term survivors of testicular cancer with chronic cancer-related fatigue. Brain Behav. Immun. 2009, 23:868-874.
61. Orre I.J., Reinertsen K.V., Aukrust P., Dahl A.A., Fosså S.D., Ueland T., Murison R. Higher levels of fatigue are associated with higher CRP levels in disease-free breast cancer survivors. J. Psychosom. Res. 2011, 71:136-141.
62. Papadopoulos A.S., Cleare A.J. Hypothalamic-pituitary-adrenal axis dysfunction in chronic fatigue syndrome. Nat. Rev. Endocrinol. 2011, 8:22-32.
63. Prins J., van der Meer J., Bleijenberg G. Chronic fatigue syndrome. Lancet 2006, 367(9507):346-355.
64. Radice, D., and Redaelli, A., 2003. Breast cancer management: quality-of-life and cost considerations. Pharmacoeconomics. 21, 383-396. Review.
65. Raison C.L., Lin J.M., Reeves W.C. Association of peripheral inflammatory markers with chronic fatigue in a population-based sample. Brain Behav. Immun. 2009, 23:327-337.
66. Rajeevan M.S., Smith A.K., Dimulescu I., Unger E.R., Vernon S.D., Heim C., Reeves W.C. Glucocorticoid receptor polymorphisms and haplotypes associated with chronic fatigue syndrome. Genes Brain Behav. 2007, 6:167-176.
67. Reyes M., Nisenbaum R., Hoaglin D.C. Prevalence and incidence of chronic fatigue syndrome in Wichita. Kansas Arch. Int. Med. 2003, 163:1530-1536.
68. Rezaieyazdi Z., Sahebari M., Hatef M.R., Abbasi B., Rafatpanah H., Afshari J.T., Esmaily H. Is there any correlation between high sensitive CRP and disease activity in systemic lupus erythematosus?. Lupus 2011, 20:1494-1500.
69. Roberts A.D., Charler M.L., Papadopoulos A., Wessely S., Chalder T., Cleare A.J. Does hypocortisolism predict a poor response to cognitive behavioral therapy in chronic fatigue syndrome?. Psychol. Med. 2010, 40:515-522.
70. Robinson M., Gray S.R., Watson M.S., Kennedy G., Hill A., Belch J.J., Nimmo M.A. Plasma IL-6, its soluble receptors and F2-isoprostanes at rest and during exercise in chronic fatigue syndrome. Scand. J. Med. Sci. Sports 2010, 20:282-290.
71. Schubert C., Hong S., Natarajan L., Mills P.J., Dimsdale J.E. The association between fatigue and inflammatory marker levels in cancer patients: a quantitative review. Brain Behav. Immun. 2007, 21:413-427.
72. Schutzer S.E., Angel T.E., Liu T., Schepmoes A.A., Clauss T.R., Adkins J.N., Camp D.G., Holland B.K., Bergquist J., Coyle P.K., Smith R.D., Fallon B.A., Natelson B.H. Distinct cerebrospinal fluid proteomes differentiate post-treatment lyme disease from chronic fatigue syndrome. PLoS One 2011, 6(2):e17287.
73. Sherry C.L., Kramer J.M., York J.M., Freund G.G. Behavioral recovery from acute hypoxia is reliant on leptin. Brain Behav. Immun. 2009, 23:169-175.
74. Silverman M.N., Heim C.M., Nater U.M., Marques A.H., Sternberg E.M. Neuroendocrine and immune contributors to fatigue. PMR 2010, 2:338-346.
75. Spence V.A., Kennedy G., Belch J.J., Hill A., Khan F. Low-grade inflammation and arterial wave reflection in patients with chronic fatigue syndrome. Clin. Sci. (London) 2008, 114:561-566.
76. Stebbings S., Herbison P., Doyle T.C., Treharne G.J., Highton J. A comparison of fatigue correlates in rheumatoid arthritis and osteoarthritis: disparity in associations with disability, anxiety and sleep disturbance. Rheumatology (Oxford) 2010, 49:361-367.
77. Thornton L.M., Andersen B.L., Blakely W.P. The pain, depression, and fatigue symptom cluster in advanced breast cancer: covariation with the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. Health Psychol. 2010, 29:333-337.
78. Torres-Harding S., Sorenson M., Jason L.A., Reynolds N., Brown M., Maher K., Fletcher M.A. The associations between basal salivary cortisol levels and illness symptomatology in chronic fatigue syndrome. J. Appl. Biobehav. Res. 2009, 13:157-160.
79. Wang X.S., Shi Q., Williams L.A., Mao L., Cleeland C.S., Komaki R.R., Mobley G.M., Liao Z. Inflammatory cytokines are associated with the development of symptom burden in patients with NSCLC undergoing concurrent chemoradiationtherapy. Brain Behav. Immun. 2010, 24:968-974.
80. Watanabe Y., Evengård B., Natelson B.H., Jason L.A. Preface and mini-review. Fatigue Science for Human Health 2008, 5-11. Springer, New York. H. Kuratsune (Ed.).
81. White A.T., Light A.R., Hughen R.W., Vanhaitsma T.A., Light K.C. Differences in metabolite-detecting, adrenergic, and immune gene expression after moderate exercise in patients with chronic fatigue syndrome, patients with multiple sclerosis, and healthy controls. Psychosom. Med. 2012, 74:46-54.
82. White A.T., Light A.R., Hughen R.W., Bateman L., Martins T.B., Hill H.R., Light K.C. Severity of symptom flare after moderate exercise is linked to cytokine activity in chronic fatigue syndrome. Psychophysiology 2010, 47:615-624.
83. Whistler T., Fletcher M.A., Lonergan W., Zeng X.R., Lin J.M., Laperriere A., Vernon S.D., Klimas N.G. Impaired immune function in Gulf War Illness. BMC Med. Genomics 2009, 2:12.